Our 2019 Season Sponsors

204: A One-of-a-Kind Advantage | Sam Santhosh, CEO, MedGenome


Fifteen years ago, when the National Human Genome Research Institute (NHGRI) announced the successful completion of the Human Genome Project, Sam Santhosh decided that it was time to study up and find all of what was required to compete inside the world of DNA sequencing. The way that Santhosh saw it, sequencing was really about data, a world he felt he understood well and one that he was confident would yield future business opportunities. Still, the unique opportunity that would give rise to MedGenome would first escape Santhosh’s lines of sight. The opportunity: India’s historic caste structure is responsible for creating an unusual human patchwork where the population is divided into distinct groups with striking genetic differences. In the genomic world, India’s unusual population patchwork provides a yet unmatched genetic pool to test and accelerate new medical therapies—while providing insights for drug development and precision medicine. Join us when Sam explains how the opportunity came more fully into view and how building a research capability in India became the first stage in pursuing a bigger data vision.

Listen to the COMPLETE EPISODE Below (00:31:37)

Data & Genetics: When Two Worlds Converge

“Back in the mid-2000s, I became aware of what was happening in the genomics world and the progress in DNA sequencing. I saw a lot of new technologies emerging that would make DNA sequencing faster and cheaper. And from the perspective of my software background, the opportunity was clear. My view was:  ‘Hey, this is just data at the end of the day.'”

Guest: Sam Santhosh, CEO

Company: MedGenome

Headquartered: Foster City, CA

Contact: www.medgenome.com    (titter) @MedGenomeLabs

Middle Market Thought Leader is Made Possible By BlacklineU.S. Bank RGB color JPG (1)

, ,

No comments yet.

Leave a Reply